BIOPORTO DIAGNOSTICS A/S: Financial statements 2017
CVR: 18645882
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
BIOPORTO DIAGNOSTICS A/S (CVR 18645882) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 25,977,183 and a net result of DKK -35,280,800 compared with DKK -28,940,140 the year before. That is an increase of 25.4% compared with the year before. The profit margin was -135.8%. Equity in the 2017 report amounted to DKK -250,977,269. The company had 16 employees in the financial year.
- Revenue
- DKK 25,977,183
- Gross Profit
- DKK -2,903,468
- Profit/Loss
- DKK -35,280,800
- Equity
- DKK -250,977,269
- Total Assets
- DKK 22,902,025
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 26 mio. | -2.9 mio. | -35.3 mio. | -251 mio. | 16 |
| 2016 | 20.7 mio. | 6 mio. | -28.9 mio. | -216.1 mio. | 19 |
| 2015 | 20.4 mio. | 5.5 mio. | -17.5 mio. | -187.9 mio. | 17 |
| 2014 | 18.7 mio. | 4.6 mio. | -22.8 mio. | -170.4 mio. | - |
| 2013 | 16.6 mio. | -1.2 mio. | -20.6 mio. | -146.4 mio. | - |
Official annual report
Keep an eye on BIOPORTO DIAGNOSTICS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
BIOPORTO DIAGNOSTICS A/S has published its annual report for 2016. Revenue came to DKK 20,720,135, and the net result was DKK -28,940,140.
About BIOPORTO DIAGNOSTICS A/S
BIOPORTO DIAGNOSTICS A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1995. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ANTIBODYSHOP A/S and IMMUNOLEX ApS. The management consists of Carsten Buhl. The board consists of Gry Louise Husby Larsen (chair), Carsten Buhl and Klaus Juhl Wulff. The company is owned by BIOPORTO A/S. The company has 29 employees (2026). In 2025, the company reported revenue of DKK 40,286,970 and a net result of DKK -81,398,096 compared with DKK -110,908,377 the year before. Equity in the 2025 report amounted to DKK -837,580,713.